FilingSpy

EDIT

Editas Medicine Inc

Clinical-stage biotechnology company focused on CRISPR gene editing therapies

CUSIP: 28106W103HealthcareUS1 holder

EDIT — Editas Medicine Inc - FilingSpy

Editas Medicine Inc

Clinical-stage biotechnology company focused on CRISPR gene editing therapies

CUSIP: 28106W103HealthcareUS1 holder

Revenue

Net Income

Gross

Operating

Net

Operating CF

Free CF

Assets

Liabilities

Equity

Cash

Long-Term Debt